Suppr超能文献

陶瓷成分对由双酚A-双甲基丙烯酸缩水甘油酯/三乙二醇二甲基丙烯酸酯树脂和生物活性玻璃陶瓷组成的生物活性骨水泥中头孢氨苄释放的影响。

Effects of ceramic component on cephalexin release from bioactive bone cement consisting of Bis-GMA/TEGDMA resin and bioactive glass ceramics.

作者信息

Otsuka M, Fujita H, Nakamura T, Kokubo T

机构信息

Department of Pharmaceutical Technology, Kobe Pharmaceutical University, Higashi-Nada, Japan.

出版信息

Biomed Mater Eng. 2001;11(1):11-22.

Abstract

The purpose of this study was to elucidate the effect of amount of ceramic cement powder on drug release from bioactive bone cement. The associated bone-bonding strength was also investigated. The bioactive bone cement under investigation consisted of bisphenol-alpha-glycidyl methacrylate (Bis-GMA), triethylene-glycol dimethacrylate (TEGDMA) resin and a combination of apatite- and wollastonite-containing glass-ceramic (A-W GC) powder. A-W GC powder (50%, 70% and 80% w/w) containing 5% cephalexin (CEX) powder hardened within 5 min after mixing with Bis-GMA/TEGDMA resin. The compressive strength of the cement with or without drug increased with increasing the amount of ceramic powder. The compressive strength of the 80% ceramic cement without the incorporation of cephalexin was 194 MPa. This compressive strength was about 3 times higher than that for polymethylmethacrylate cement. After the cement was implanted in the proximal metaphysis of the tibiae of male rabbits, the failure load for the cement was found to increase with increasing of the amount of ceramic powder. This finding suggested that the cement formed a bonding with bone. In vitro CEX release from bioactive bone cement pellets in a simulated body fluid at pH 7.25 and 37 degrees C continued for more than 2 weeks. Drug release profile followed the Higuchi equation initially, but not at later stages. The drug release rate increased with increasing amount of ceramic powder in the mixture. Since the pore volume of the cement increased with increasing of amount of ceramic powder, the drug diffused in the pores between the ceramics particle and polymer matrix. As hydroxyapatite precipitated on the cement surface, the drug release rate decreased, as observed at the later release stage. These results suggest that varying the amount of ceramic powder in the cement system could control the drug release rate from bioactive bone cement.

摘要

本研究的目的是阐明陶瓷骨水泥粉末用量对生物活性骨水泥药物释放的影响。同时还研究了相关的骨结合强度。所研究的生物活性骨水泥由双酚-α-甲基丙烯酸缩水甘油酯(Bis-GMA)、三乙二醇二甲基丙烯酸酯(TEGDMA)树脂以及含磷灰石和硅灰石的微晶玻璃(A-W GC)粉末组成。含有5%头孢氨苄(CEX)粉末的A-W GC粉末(50%、70%和80% w/w)与Bis-GMA/TEGDMA树脂混合后在5分钟内硬化。含药或不含药水泥的抗压强度随陶瓷粉末用量的增加而增加。未加入头孢氨苄的80%陶瓷水泥的抗压强度为194 MPa。该抗压强度约为聚甲基丙烯酸甲酯水泥的3倍。将水泥植入雄性兔胫骨近端干骺端后,发现水泥的破坏载荷随陶瓷粉末用量的增加而增加。这一发现表明该水泥与骨形成了结合。在pH 7.25和37℃的模拟体液中,生物活性骨水泥微丸的体外CEX释放持续了2周以上。药物释放曲线最初遵循Higuchi方程,但在后期并非如此。药物释放速率随混合物中陶瓷粉末用量的增加而增加。由于水泥的孔隙体积随陶瓷粉末用量的增加而增加,药物在陶瓷颗粒与聚合物基质之间的孔隙中扩散。正如在后期释放阶段所观察到的,随着羟基磷灰石在水泥表面沉淀,药物释放速率降低。这些结果表明,改变水泥体系中陶瓷粉末的用量可以控制生物活性骨水泥的药物释放速率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验